APOA1 and cancer: ApoA-I is closely associated with the onset, progression, and prognosis of various cancer types, including renal cell carcinoma (13), esophageal squamous cell carcinoma (14), nasopharyngeal carcinoma (15), ovarian cancer (16), non-small cell lung cancer (17), and bladder cancer (18).